These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16312479)

  • 1. Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans.
    Scaringi L; Rosati M; Bistoni F; Cassone A; Marconi P
    J Chemother; 1989 Jul; 1(4 Suppl):446-8. PubMed ID: 16312479
    [No Abstract]   [Full Text] [Related]  

  • 2. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro.
    Scaringi L; Blasi E; Rosati E; Marconi P; Bistoni F
    J Gen Microbiol; 1991 Dec; 137(12):2851-6. PubMed ID: 1791439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of the interaction of murine phagocytic cells with Candida albicans.
    Morrison RP; Cutler JE
    J Reticuloendothel Soc; 1981 Jan; 29(1):23-34. PubMed ID: 7009855
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease.
    Takahashi K; Oharaseki T; Wakayama M; Yokouchi Y; Naoe S; Murata H
    Inflamm Res; 2004 Feb; 53(2):72-7. PubMed ID: 15021972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo modulation of lymphokine-activated killer cell activity by cell wall components of Candida albicans.
    Scaringi L; Rosati E; Cornacchione P; Rossi R; Marconi P
    Cell Immunol; 1992 Feb; 139(2):438-54. PubMed ID: 1733513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of monocytes by IL-2-activated killer cells.
    Djeu JY; Wei S; Blanchard DK
    Immunol Ser; 1994; 61():75-82. PubMed ID: 8011758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma].
    Tissi L; Scaringi L; Cassone A; D'Errico P; Marconi P
    G Ital Chemioter; 1984; 31(1-2):91-100. PubMed ID: 6381211
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha secretion by splenocytes of Candida albicans infected mice.
    Vecchiarelli A; Puliti M; Blasi E; Bistoni F
    J Chemother; 1989 Jul; 1(4 Suppl):1170-1. PubMed ID: 16312819
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphokine toxicity for yeast cells.
    Pearsall NN; Sundsmo JS; Weiser RS
    J Immunol; 1973 May; 110(5):1444-6. PubMed ID: 4572637
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytokines secreted by IL-2-activated lymphocytes induce endogenous nitric oxide synthesis and apoptosis in macrophages.
    Choi KS; Song EK; Yim CY
    J Leukoc Biol; 2008 Jun; 83(6):1440-50. PubMed ID: 18339892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis.
    Toth LA; Hughes LF
    Comp Med; 2006 Aug; 56(4):252-61. PubMed ID: 16941952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of Candida albicans by interleukin-2-activated splenocytes.
    Beno DW; Mathews HL
    Infect Immun; 1992 Mar; 60(3):853-63. PubMed ID: 1541559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of various human interleukin-2 preparations and lymphokine-activated killer cells on antibody production in mice in vivo and human immunoglobulins in vitro].
    Potapnev MP; Garbuzenko TS; Vozniuk AV; Ruksha EV; Shadrin OV; Bykovskaia SN
    Biull Eksp Biol Med; 1994 Aug; 118(8):171-3. PubMed ID: 7949042
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of intensity of Trichinella invasion on the phagocytosis of Candida albicans by mice macrophages].
    Szkudlinski J
    Wiad Parazytol; 2001; 47(4):661-6. PubMed ID: 16886407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aging on murine neutrophil and macrophage function against Candida albicans.
    Murciano C; Yáñez A; O'Connor JE; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):214-21. PubMed ID: 18445021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
    Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
    Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific and nonspecific immunomodulation by wall components of Candida albicans.
    Domer JE
    J Chemother; 1989 Jul; 1(4 Suppl):441-3. PubMed ID: 16312478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.